表紙
市場調查報告書

鼻腔給藥技術的全球市場 - 預測:2020年∼2030年

Nasal Drug Delivery Technology Market Forecast 2020-2030: Sprays, Non-Pressurized/Pressurized Containers, Drops & Liquids, Gels, Powders, Multi-Dose, Bi-Dose & Unit Dose Nasal Devices; Allergic & Non-Allergic Rhinitis, Congestion, Asthma, Other

出版商 Visiongain Ltd 商品編碼 935846
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
鼻腔給藥技術的全球市場 - 預測:2020年∼2030年 Nasal Drug Delivery Technology Market Forecast 2020-2030: Sprays, Non-Pressurized/Pressurized Containers, Drops & Liquids, Gels, Powders, Multi-Dose, Bi-Dose & Unit Dose Nasal Devices; Allergic & Non-Allergic Rhinitis, Congestion, Asthma, Other
出版日期: 2020年03月30日內容資訊: 英文 185 Pages
簡介

全球鼻腔給藥技術市場在2019年估算達到443億8500萬美元,在2020年∼2025年前預計將以年複合成長率7.8%的速度成長。

本報告提供全球鼻腔給藥技術市場相關調查分析,提供市場概要,市場動態,市場預測,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 鼻腔給藥技術市場簡介

  • 鼻腔給藥技術市場結構

第3章 全球鼻腔給藥技術市場

  • 市場動態
  • 市場的推動要素與課題
  • 醫療設備的法規
  • 波特的五力分析

第4章 全球鼻腔給藥技術市場預測:不同投藥形態

  • 鼻噴霧
  • 滴鼻劑·液體
  • 點鼻凝膠
  • 點鼻粉末

第5章 全球鼻腔給藥技術市場預測:各系統

  • 單位用量
  • 2次給藥
  • 多劑量

第6章 全球鼻腔給藥技術市場預測:各適應症

  • 氣喘
  • 過敏性/非過敏性鼻炎
  • 鼻塞
  • 其他

第7章 全球鼻腔給藥技術市場預測:各終端用戶

  • 門診病人手術中心
  • 醫院
  • 專門診所
  • 疫苗接種中心

第8章 主要國家市場

  • 北美
  • 南美
  • 西歐
  • 北歐
  • 東歐
  • 亞太地區
  • 中東·非洲

第9章 鼻腔給藥技術市場主要企業

第10章 結論

第11章 簡稱

目錄
Product Code: PHA0549

The Global Nasal Drug Delivery Technology Market is estimated at $44,385 m in 2019 and is expected to grow at a CAGR of 7.8% from 2020-2025. In 2019, the Global Nasal Drug Delivery Technology Market was dominated by the nasal sprays submarket which held 33.2% of the overall market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 185-page report you will receive 54 charts- all unavailable elsewhere.

The 185-page report provides clear detailed insight into the Global Nasal Drug Delivery Technology Market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope:

Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology market.

Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by the dosage form:

  • Dosage Form: Nasal Sprays, Nasal Drops & Liquids, Nasal Gels, Nasal Powders
  • Nasal Sprays: Non-pressurized Containers and Pressurized Containers

Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by System:

  • Nasal Unidose Devices
  • Nasal Bi Dose Devices
  • Nasal Multi Dose Devices

Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by Application:

  • Asthma
  • Allergic and Non-Allergic Rhinitis
  • Nasal Congestion

Revenue and growth forecasts from 2020 to 2030 for the Global Nasal Drug Delivery Technology Market by End User:

  • Hospitals
  • Ambulatory Surgery Center
  • Specialty Clinics
  • Vaccination Centers

Revenue and growth forecasts from 2020 to 2030 for the leading national markets:

  • United States
  • Canada
  • Brazil
  • Mexico
  • Rest of Latin America
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Nordic
  • Benelux
  • Rest of Western Europe
  • Russia
  • Poland
  • Rest of Eastern Europe
  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia-Pacific
  • GCC Countries
  • South Africa
  • North Africa
  • Rest of MEA

This report profiles the leading companies that market nasal drug delivery devices:

  • 3M Company
  • Becton, Dickinson and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teleflex Incorporated
  • Naveh Pharma Ltd.
  • OptiNose US, Inc.
  • Pendopharm
  • AptarGroup, Inc.

This report provides qualitative analysis of the Global Nasal Drug Delivery Technology market. This report discusses the Porter's Five Forces Analysis, as well as the Drivers and Challenges of this market.

Visiongain's study is intended for anyone requiring commercial analyses for the Global Digital Wound Care Management market. You find data, trends and predictions.

Buy our report today Nasal Drug Delivery Technology Market Forecast 2020-2030: Nasal Sprays: Non-Pressurised Containers & Pressurised Containers, Nasal Drops & Liquids, Nasal Gels, Nasal Powders; Multi Dose Nasal Devices, Bi-Dose Nasal Devices, Unit Dose Nasal Devices; Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma; Ambulatory Surgery Centres, Hospitals, Specialty Clinics, Vaccination Centres.

Visiongain is a trading partner with the US Federal Government.

TABLE OF CONTENTS

1. REPORT OVERVIEW

  • 1.1GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET OVERVIEW
  • 1.2 WHY YOU SHOULD READ THIS REPORT
  • 1.3 HOW THIS STUDY DELIVERS
  • 1.4 MAIN QUESTIONS ANSWERED BY THE ANALYSIS
  • 1.5 WHO IS THIS INVESTIGATION FOR?
  • 1.6 METHOD OF RESEARCH AND ANALYSIS
  • 1.7 FREQUENTLY ASKED QUESTIONS (FAQS)
  • 1.8 ABOUT VISIONGAIN

2. INTRODUCTION TO NASAL DRUG DELIVERY TECHNOLOGY MARKET

  • 2.1 NASAL DRUG DELIVERY TECHNOLOGY MARKET STRUCTURE
    • 2.1.1 NASAL DRUG DELIVERY TECHNOLOGY MARKET DEFINITION
    • 2.1.2 NASAL DRUG DELIVERY ROUTE

3. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET 2019-2030

  • 3.1 NASAL DRUG DELIVERY TECHNOLOGY MARKET DYNAMICS
  • 3.2 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET DRIVERS AND CHALLENGES 2019
    • 3.2.1 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET DRIVERS 2019
      • 3.2.1.1 INCREASING PREVALENCE OF RESPIRATORY DISEASES
      • 3.2.1.2 GROWING ADOPTION OF SELF-ADMINISTRATION PRACTICES
      • 3.2.1.3 RAPIDLY AGING POPULATION
      • 3.2.1.4 INCREASING PREFERENCE FOR NASAL DRUG DELIVERY ROUTE
      • 3.2.1.5 INCREASING APPLICATIONS OF NASAL DRUG DELIVERY TECHNOLOGY
      • 3.2.1.6 TECHNOLOGICAL ADVANCEMENTS IN NASAL DRUG DELIVERY
      • 3.2.1.7 BI-DIRECTIONAL NASAL DRUG DELIVERY
    • 3.2.2 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET CHALLENGES 2019
      • 3.2.2.1 COMPLICATIONS OF OVERUSE OF NASAL SPRAYS AND NASAL POWDERS
    • 3.2.3 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET OPPORTUNITIES 2019
      • 3.2.3.1 OVER-THE-COUNTER (OTC) NASAL DRUGS
      • 3.2.3.2 NOSE-TO-BRAIN DRUG DELIVERY ROUTE
      • 3.2.3.3 EMERGING MARKETS
      • 3.2.3.4 PRODUCT LAUNCHES IN THE NASAL DRUG DELIVERY TECHNOLOGY MARKET
  • 3.3 REGULATION OF MEDICAL DEVICES
    • 3.3.1 THE US APPROVAL AND REGULATION SYSTEM
    • 3.3.2 THE EU APPROVAL AND REGULATION SYSTEM
      • 3.3.2.1 POST-MARKETING SURVEILLANCE IN THE EU
  • 3.4 PORTER'S FIVE FORCES ANALYSIS
    • 3.4.1 BARGAINING POWER OF THE SUPPLIERS
    • 3.4.2 BARGAINING POWER OF THE BUYERS
    • 3.4.3 THREAT OF NEW ENTRANTS
    • 3.4.4 HIGH INTENSITY OF RIVALRY
    • 3.4.5 THREAT OF SUBSTITUTES

4. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET BY DOSAGE FORM FORECAST 2020-2030

  • 4.1 NASAL SPRAYS MARKET 2020-2030
    • 4.1.1.1 NASAL SPRAYS MARKET FOR PRESSURIZED CONTAINERS 2020-2030
    • 4.1.1.2 NASAL SPRAYS MARKET FOR NON-PRESSURIZED CONTAINERS 2020-2030
  • 4.2 NASAL DROPS & LIQUIDS MARKET 2020-2030
  • 4.3 NASAL GELS MARKET 2020-2030
  • 4.5 NASAL POWDERS MARKET 2020-2030

5. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET BY SYSTEM FORECAST 2020-2030

  • 5.1 UNIT DOSE NASAL DRUG DELIVERY SYSTEM MARKET 2020-2030
  • 5.2 BI-DOSE DOSE NASAL DRUG DELIVERY SYSTEM MARKET 2020-2030
  • 5.3 MULTI-DOSE NASAL DRUG DELIVERY SYSTEM MARKET 2020-2030

6. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET BY APPLICATION FORECAST 2020-2030

  • 6.1 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR ASTHMA 2020-2030
  • 6.2 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR ALLERGIC & NON-ALLERGIC RHINITIS 2020-2030
  • 6.3 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR NASAL CONGESTION 2020-2030
  • 6.4 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER APPLICATIONS 2020-2030
  • 6.5 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER APPLICATIONS FORECAST 2020-2030

7. GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET BY END USER FORECAST 2020-2030

  • 7.1 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR AMBULATORY SURGERY CENTERS (ASCS) 2020-2030
  • 7.2 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR HOSPITALS 2020-2030
  • 7.3 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR SPECIALTY CLINICS 2020-2030
  • 7.4 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR VACCINATION CENTERS 2020-2030

8. LEADING NATIONAL MARKETS 2020-2030

  • 8.1 NORTH AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.1.1 US NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.1.2 CANADA NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
  • 8.2 LATIN AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.2.1 BRAZIL NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.2.2 MEXICO NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.2.3 REST OF LATIN AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
  • 8.3 WESTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.3.1 GERMANY NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.3.2 FRENCH NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.3.3 UK NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.3.4 SPANISH NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.3.5 ITALY NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
  • 8.3.6NORDIC NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.3.7 BENELUX NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.3.8 REST OF WESTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
  • 8.4 EASTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.4.1 RUSSIA NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.4.2 POLAND NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.4.3 REST OF EASTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
  • 8.5 ASIA-PACIFIC NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.5.1 THE JAPANESE NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.5.2 THE CHINESE NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.5.3 THE INDIAN NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.5.4 AUSTRALIA & NEW ZEALAND NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.5.6 ASEAN NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.5.7 REST OF ASIA-PACIFIC NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
  • 8.6 MEA NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.6.1 GCC COUNTRIES NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.6.2 SOUTH AFRICA NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.6.3 NORTH AFRICA NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030
    • 8.6.4 REST OF MEA NASAL DRUG DELIVERY TECHNOLOGY MARKET 2020-2030

9. LEADING COMPANIES IN THE NASAL DRUG DELIVERY TECHNOLOGY MARKET

  • 9.1 NOVARTIS AG
    • 9.1.1BUSINESS OVERVIEW
    • 9.1.2COMPANY SNAPSHOT
    • 9.1.3 NOVARTIS AG: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
    • 9.1.4 NOVARTIS AG: FINANCIALS
    • 9.1.5 NOVARTIS AG: RECENT DEVELOPMENTS
  • 9.2 3M COMPANY
    • 9.2.1BUSINESS OVERVIEW
    • 9.2.2COMPANY SNAPSHOT
    • 9.2.3 3M COMPANY: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
    • 9.2.4 3M COMPANY: FINANCIALS
  • 9.3 BECTON, DICKINSON AND COMPANY
    • 9.3.1BUSINESS OVERVIEW
    • 9.3.2 COMPANY SNAPSHOT
    • 9.3.3 BECTON, DICKINSON AND COMPANY: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
    • 9.3.4 BECTON, DICKINSON AND COMPANY: FINANCIALS
  • 9.4 GLAXOSMITHKLINE PLC
    • 9.4.1 BUSINESS OVERVIEW
    • 9.4.2 COMPANY SNAPSHOT
    • 9.4.3 GLAXOSMITHKLINE PLC: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
    • 9.4.4 GLAXOSMITHKLINE PLC: FINANCIALS
    • 9.4.5 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS
  • 9.5 JOHNSON & JOHNSON
    • 9.5.1 BUSINESS OVERVIEW
    • 9.5.2 COMPANY SNAPSHOT
    • 9.5.3 JOHNSON & JOHNSON: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
    • 9.5.4 JOHNSON & JOHNSON: FINANCIALS
    • 9.5.5 JOHNSON & JOHNSON: RECENT DEVELOPMENTS
  • 9.6 MERCK & CO., INC.
    • 9.6.1 BUSINESS OVERVIEW
    • 9.6.2 COMPANY SNAPSHOT
    • 9.6.3 MERCK & CO., INC.: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
    • 9.6.4 MERCK & CO., INC.: FINANCIALS
    • 9.6.5 MERCK & CO., INC.: RECENT DEVELOPMENTS
  • 9.7 PFIZER INC.
    • 9.7.1 BUSINESS OVERVIEW
    • 9.7.2 COMPANY SNAPSHOT
    • 9.7.3 PFIZER INC.: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
  • 9.8 TELEFLEX INCORPORATED
    • 9.8.1 BUSINESS OVERVIEW
    • 9.8.2 COMPANY SNAPSHOT
    • 9.8.3 TELEFLEX INCORPORATED: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
    • 9.8.4 TELEFLEX INCORPORATED: FINANCIALS
  • 9.9 NAVEH PHARMA LTD.
    • 9.9.1 BUSINESS OVERVIEW
    • 9.9.2 COMPANY SNAPSHOT
    • 9.9.3 NAVEH PHARMA LTD.: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
  • 9.10 B.F. ASCHER & CO., INC.
    • 9.10.1 BUSINESS OVERVIEW
    • 9.10.2 COMPANY SNAPSHOT
    • 9.10.3 B.F. ASCHER & CO., INC.: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
  • 9.11 ENT TECHNOLOGIES PTY LTD
    • 9.11.1 BUSINESS OVERVIEW
    • 9.11.2 COMPANY SNAPSHOT
    • 9.11.3 ENT TECHNOLOGIES PTY LTD: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
  • 9.12 OPTINOSE US, INC.
    • 9.12.1 BUSINESS OVERVIEW
    • 9.12.2 COMPANY SNAPSHOT
    • 9.12.3 OPTINOSE US, INC.: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
    • 9.12.4 OPTINOSE INC.: FINANCIALS
    • 9.12.5 OPTINOSE US, INC.: RECENT DEVELOPMENTS
  • 9.13 PENDOPHARM
    • 9.13.1 BUSINESS OVERVIEW
    • 9.13.2 COMPANY SNAPSHOT
    • 9.13.3 PENDOPHARM: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
  • 9.14 APTARGROUP, INC.
    • 9.14.1 BUSINESS OVERVIEW
    • 9.14.2 COMPANY SNAPSHOT
    • 9.14.3 APTARGROUP, INC.: NASAL DRUG DELIVERY TECHNOLOGY PRODUCT PORTFOLIO
    • 9.14.4 APTARGROUP, INC.: FINANCIALS

10. CONCLUSION

  • 10.1 THE WORLD NASAL DRUG DELIVERY TECHNOLOGY MARKET IN 2019 AND 2020
  • 10.2 CURRENT LEADING NASAL DRUG DELIVERY TECHNOLOGY SEGMENTS, BY DOSAGE FORM
  • 10.3 LEADING NASAL DRUG DELIVERY TECHNOLOGY COMPANIES
  • 10.4 LEADING REGIONAL MARKETS
  • 10.5 WORLD NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030
  • 10.6 THE FUTURE OF THE NASAL DRUG DELIVERY TECHNOLOGY MARKET?

11. ABBREVIATION

  • ASSOCIATED VISIONGAIN REPORTS
  • VISIONGAIN REPORT SALES ORDER FORM
  • APPENDIX A
  • APPENDIX B

LIST OF TABLES

  • TABLE 1.1 WORLD NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 3.1 DEMOGRAPHIC DEVELOPMENT: INCREASING GROWTH IN THE 65+ POPULATION
  • TABLE 4.1NASAL DRUG DELIVERY TECHNOLOGY MARKET BY DOSAGE FORM FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 4.2 DIFFERENT TYPES OF NASAL SPRAYS
  • TABLE 4.3NASAL SPRAYS MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 4.4 NASAL SPRAYS MARKET FOR PRESSURIZED CONTAINERS FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 4.5 NASAL SPRAYS MARKET FOR NON-PRESSURIZED CONTAINERS FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 4.6 NASAL DROPS AND LIQUIDS MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 4.7 NASAL GELS MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019- 2030
  • TABLE 5.2 NASAL POWDERS
  • TABLE 4.8 NASAL POWDERS MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 5.1NASAL DRUG DELIVERY TECHNOLOGY MARKET BY SYSTEM FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 5.2 DRUGS FOR UNIT DOSE SYSTEMS
  • TABLE 5.3 UNIT DOSE NASAL DRUG DELIVERY SYSTEM MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 5.4 BI DOSE NASAL DRUG DELIVERY SYSTEM MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 5.5 DRUGS FOR MULTI-DOSE SYSTEMS
  • TABLE 5.6 MULTI DOSE NASAL DRUG DELIVERY SYSTEM MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 6.1NASAL DRUG DELIVERY TECHNOLOGY MARKET BY APPLICATION FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 6.2 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR ASTHMA FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 6.2 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR ALLERGIC AND NONALLERGIC RHINITIS FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 6.3 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR NASAL CONGESTION FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 6.4NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER APPLICATIONS FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 7.1NASAL DRUG DELIVERY TECHNOLOGY MARKET BY END USER FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 7.2NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR ASCS FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 7.3 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR HOSPITALS FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 7.4NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR SPECIALTY CLINICS FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 7.5 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR VACCINATION CENTERS FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.1NORTH AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.2US NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.4CANADA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.6 LATIN AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.6 BRAZIL NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.7 MEXICO NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.7 REST OF LATIN AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.6 WESTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.6 GERMANY NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.7FRENCH NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.8UK NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.9SPANISH NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.10ITALY NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.10 NORDIC NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.10 BENELUX NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.10 REST OF WESTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.11 EASTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.11 RUSSIA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.12 POLAND NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.13 REST OF EASTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.11 ASIA-PACIFIC NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.11JAPANESE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.12CHINESE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.13INDIAN NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.14AUSTRALIA & NEW ZEALAND NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.15 ASEAN NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.15 REST OF ASIA-PACIFIC NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.15 MEA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.15 GCC COUNTRIES NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.15 SOUTH AFRICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.15 NORTH AFRICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 8.15 REST OF MEA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020-2030 (US$M, AGR %, & CAGR %), 2019-2030
  • TABLE 9.1 NOVARTIS AG: COMPANY SNAPSHOT
  • TABLE 9.2 NOVARTIS AG: PRODUCT PORTFOLIO
  • TABLE 9.3 3M COMPANY: COMPANY SNAPSHOT
  • TABLE 9.4 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 9.5 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
  • TABLE 9.6 GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
  • TABLE 9.6 JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 9.7 MERCK & CO., INC.: COMPANY SNAPSHOT
  • TABLE 9.8 PFIZER INC.: COMPANY SNAPSHOT
  • TABLE 9.9 PFIZER INC.: PRODUCT PORTFOLIO
  • TABLE 9.10 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • TABLE 9.11 NAVEH PHARMA LTD.: COMPANY SNAPSHOT
  • TABLE 9.12 NAVEH PHARMA LTD.: PRODUCT PORTFOLIO
  • TABLE 9.13 B.F. ASCHER & CO., INC.: COMPANY SNAPSHOT
  • TABLE 9.14 B.F. ASCHER & CO., INC.: PRODUCT PORTFOLIO
  • TABLE 9.15 ENT TECHNOLOGIES PTY LTD: COMPANY SNAPSHOT
  • TABLE 9.16 ENT TECHNOLOGIES PTY LTD: PRODUCT PORTFOLIO
  • TABLE 9.17 OPTINOSE US, INC.: COMPANY SNAPSHOT
  • TABLE 9.18 OPTINOSE US, INC.: PRODUCT PORTFOLIO
  • TABLE 9.19 PENDOPHARM: COMPANY SNAPSHOT
  • TABLE 9.20PENDOPHARMA: PRODUCT PORTFOLIO
  • TABLE 9.21 APTARGROUP, INC.: COMPANY SNAPSHOT
  • TABLE 9.22 APTARGROUP, INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 2.1 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET SEGMENTATION OVERVIEW
  • FIGURE 3.6 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET: DRIVERS AND RESTRAINTS
  • FIGURE 3.1 NASAL DRUG DELIVERY TECHNOLOGY MARKET: PRODUCT LAUNCHES
  • FIGURE 3.2 PORTER'S FIVE FORCES ANALYSIS OF THE NASAL DRUG DELIVERY TECHNOLOGY MARKET, 2019-2030
  • FIGURE 4.1 NASAL SPRAYS MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 4.2 NASAL SPRAYS MARKET FOR PRESSURIZED CONTAINERS FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 4.3 NASAL SPRAYS MARKET FOR NON-PRESSURIZED CONTAINERS FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 4.4 NASAL DROPS AND LIQUIDS MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 4.5 NASAL GELS MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020- 2030
  • FIGURE 4.6 NASAL POWDERS MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 5.1 UNIT DOSE NASAL DRUG DELIVERY SYSTEM MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 5.2 BI DOSE NASAL DRUG DELIVERY SYSTEM MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 5.3 MULTI DOSE NASAL DRUG DELIVERY SYSTEM MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 6.1 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR ASTHMA FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 6.2 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR ALLERGIC AND NONALLERGIC RHINITIS FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 6.3 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR NASAL CONGESTION FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 6.4 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR OTHER APPLICATIONS FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 7.1 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR ASCS FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 7.2 NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR HOSPITALS FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 7.3NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR SPECIALTY CLINICS FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 7.4NASAL DRUG DELIVERY TECHNOLOGY MARKET FOR VACCINATION CENTERS FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.1 NORTH AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.2 US NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.8CANADA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.10 LATIN AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.10 BRAZIL NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.11 MEXICO NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.11 REST OF LATIN AMERICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.10 WESTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.10GERMANY NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.11FRENCH NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.12UK NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.13SPANISH NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST 2020- 2030 (US$M, AGR %, & CAGR %), 2019-2030
  • FIGURE 8.14ITALY NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.14 NORDIC NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.14 BENELUX NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.14 REST OF WESTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.15 EASTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.15 RUSSIA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.16 POLAND NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.17 REST OF EASTERN EUROPE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.15 ASIA-PACIFIC NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.15JAPANESE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.16CHINESE NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.17INDIAN NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.18AUSTRALIA & NEW ZEALAND NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.19 ASEAN NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.19 REST OF ASIA-PACIFIC NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.19 MEA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.19 GCC COUNTRIES NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.19 SOUTH AFRICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.19 NORTH AFRICA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 8.19 REST OF MEA NASAL DRUG DELIVERY TECHNOLOGY MARKET FORECAST: REVENUES ($MILLION) AND AGR (%), 2020-2030
  • FIGURE 9.1 NOVARTIS AG: REVENUE ($M), 2017-2019
  • FIGURE 9.2 NOVARTIS AG: BUSINESS SEGMENT % SHARE, 2019
  • FIGURE 9.3 NOVARTIS AG: GEOGRAPHICAL SEGMENT % SHARE, 2019
  • FIGURE 9.43M COMPANY: REVENUE ($M), 2017-2019
  • FIGURE 9.5 3M COMPANY: BUSINESS SEGMENT % SHARE, 2019
  • FIGURE 9.6 3M COMPANY: GEOGRAPHICAL SEGMENT % SHARE, 2019
  • FIGURE 9.7 BECTON, DICKINSON AND COMPANY: REVENUE ($M), 2017-2019
  • FIGURE 9.8 BECTON, DICKINSON AND COMPANY: BUSINESS SEGMENT % SHARE, 2019
  • FIGURE 9.9 BECTON, DICKINSON AND COMPANY: GEOGRAPHICAL SEGMENT % SHARE, 2019
  • FIGURE 9.10 GLAXOSMITHKLINE PLC: REVENUE (£M), 2017-2019
  • FIGURE 9.11 GLAXOSMITHKLINE PLC: BUSINESS SEGMENT % SHARE, 2019
  • FIGURE 9.12 GLAXOSMITHKLINE PLC: GEOGRAPHICAL SEGMENT % SHARE, 2019
  • FIGURE 9.13 JOHNSON & JOHNSON: REVENUE ($M), 2017-2019
  • FIGURE 9.14 JOHNSON & JOHNSON: BUSINESS SEGMENT % SHARE, 2019
  • FIGURE 9.15 JOHNSON & JOHNSON: GEOGRAPHICAL SEGMENT % SHARE, 2019
  • FIGURE 9.16 MERCK & CO., INC.: REVENUE ($M), 2017-2019
  • FIGURE 9.16 MERCK & CO., INC.: BUSINESS SEGMENT % SHARE, 2019
  • FIGURE 9.17 MERCK & CO., INC.: GEOGRAPHICAL SEGMENT % SHARE, 2019
  • FIGURE 9.18 TELEFLEX INCORPORATED: REVENUE ($M), 2017-2019
  • FIGURE 9.19 TELEFLEX INCORPORATED: GEOGRAPHICAL SEGMENT % SHARE, 2019
  • FIGURE 9.20 OPTINOSE INC.: REVENUE, 2018-2019
  • FIGURE 9.21 APTARGROUP, INC.: REVENUE, 2017-2019
  • FIGURE 9.22 APTARGROUP, INC.: BUSINESS SEGMENT % SHARE, 2019
  • FIGURE 9.23 APTARGROUP, INC.: GEOGRAPHICAL SEGMENT % SHARE, 2019